20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22865 | immunoglobulin light chain variable region fragment [Homo sapiens] | Others | |
Immunoglobulin light chain variable region fragment [Homo sapiens] is a fragment (Phe-Thr-Leu-Lys-Ile-Ser-Arg) on the variable region of the human immunoglobulin light chain. | |||
TP2260 | Immunoglobulin M heavy chain (IGHM) fragment [Homo sapiens] | Others | |
Immunoglobulin M heavy chain (IGHM) fragment [Homo sapiens] is a fragment (Gly-Val-Ala-Leu-His-Arg-Pro-Asp-Val-Tyr-Leu-Leu-Pro-Pro-Ala-Arg) on the human immunoglobulin micro heavy chain. Immunoglobulins (Ig) are the anti... | |||
TP2259 | immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus] | Others | |
Immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus] is a fragment on the variable region of the human and mouse immunoglobulin light chain. Immunoglobulins (Ig) are the antigen recognition m... | |||
T9917 | Denosumab | RANKL/RANK | |
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand | |||
TP2385 | Ige decapeptide | Immunoglobulin E decapeptide | |
Ige decapeptide is a peptide. | |||
T9926 | Omalizumab | Others | |
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE) | |||
T30231 | AVP-13358 | Others | |
AVP-13358 is a CD23 antagonist (immunoglobulin ε-Fc receptor antagonist), an immunoglobulin E inhibitor. AVP-13358 has potent activity against IgE, cytokines and CD23 and is used in the treatment of immune system disorde... | |||
T78269 | Anti-Mouse PD-1 Antibody (RMP1-14) | PD-1/PD-L1 | |
RMP1-14 is an IgG1-like immunoglobulin and anti-Mouse PD-1 antibody that blocks PD-1/PD-L1 signaling. | |||
T30480 | BiP inducer X | BIX | Apoptosis |
BiP inducer X (BIX) is a selective inducer of immunoglobulin heavy chain binding protein (BiP)/GRP78 and an ER chaperone inducer. BiP inducer X prevents cell death in neurons and retinal cell lines. | |||
T22889 | KF38789 | KF 38789 | Others |
KF38789 is a selective inhibitor of P-selectin-mediated cell adhesion and P-selectin immunoglobulin G chimeric protein. | |||
T76937 | Burfiralimab | hzVSF-v13 | HBV |
Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins that has anti-HBV effects and can be used to study rheumatoid arthritis, | |||
T9907 | Nivolumab | PD-1/PD-L1 | |
Nivolumab (anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune ... | |||
T39057 | Rozanolixizumab | UCB7665 | Others |
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases. | |||
T77042 | Aducanumab | BIIB037 | Beta Amyloid |
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease... | |||
T35392 | Tiragolumab | RO 7092284,RG6058-10,MTIG-7192A,RG6058-11,RG-6058 | Others |
Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatmen... | |||
T76722 | Sarilumab | REGN-88,SAR-153191 | IL Receptor |
Sarilumab (SAR-153191)is a potent interleukin-6 IL-6 receptor antagonist and a human immunoglobulin G1 monoclonal antibody. Sarilumab inhibits IL-6-mediated signaling and reduces inflammation.Sarilumab is used for the pr... | |||
T77075 | Spartalizumab | PDR001 | PD-1/PD-L1 |
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that selectively binds to PD-1 at low concentrations and shows high activity. Spartalizumab blocks the interaction with PD-L1 and PD-L2, and can ... | |||
T73133 | FGF22-IN-1 | Others | |
FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.FGF22-IN-1 inhibits the interaction between CD4 and major histocompatibility complex (MHC) class II proteins and supp... | |||
T77423 | Lirilumab | ONO-4483,IPH2102 | Virus Protease |
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-depende... | |||
T76692 | Mosunetuzumab | BTCT-4465A | Others |
Mosunetuzumab (BCT-4465A) is a humanized antibody based on immunoglobulin G1 that targets CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used to stu... |